adriamycinol has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balis, F; Cole, DE; Dombi, E; Lai, C; Lucas, N; Melani, C; Roschewski, M; Steinberg, SM; Widemann, BC; Wilson, WH | 1 |
| Andersen, A; Holte, H; Slørdal, L | 1 |
2 trial(s) available for adriamycinol and Lymphoma
| Article | Year |
|---|---|
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment.
Topics: Aged; Bilirubin; Doxorubicin; Humans; Liver Diseases; Lymphoma; Middle Aged; Rituximab | 2023 |
Pharmacokinetics and metabolism of doxorubicin after short-term infusions in lymphoma patients.
Topics: Adult; Aged; Area Under Curve; Biotransformation; Doxorubicin; Female; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Naphthacenes; Time Factors | 1999 |